Our goal at First Diagnostic Corporation is to lead in providing rapid diagnostic solutions. We strive to deliver exceptional rapid test products that are easy to use, providing quick and accurate results at the point-of-care (POC). Our unique antigen design technology, efficient expression system, antibody library, and monoclonal antibody development technology set us apart from the competition. Our main products are recombinant antigens and antibodies developed through genetic engineering technology. Our product range covers diagnosing antibodies for cardiovascular diseases, tumor markers, inflammations, liver and kidney function, pregnancy, infectious diseases, and gastric function, among others. Now we have unique antigen design technology, proprietary and efficient expression system, antibody library, and sheep monoclonal antibody development technology. The company’s main products are recombinant antigens and antibodies based on genetic engineering technology. Our product categories cover diagnosing antibodies for cardiovascular diseases, tumor markers, inflammations, liver and kidney function, pregnancy, infectious diseases, gastric function, etc.
Our STD brand, inSTIcheck™, has recently launched new urine-based rapid test kits for Chlamydia & Gonorrhea. These test kits are highly effective and have been nationally recognized in proficiency testing programs across the US. National Laboratory Professionals have acknowledged the inSTIcheck™ brand as the preferred choice due to recent external quality control program results.
First Diagnostic brand's ATFirst™, inSTIcheck™ and Home Test Express™ are marketed in over 40 countries for the rapid and early detection of various health conditions for Chlamydia • Gonorrhea • Syphilis • Cancer • H. pylori • Influenza • Legionella • Mono • Pregnancy and Fertility • RSV • Strep.